ArticleJournal of nanobiotechnology2025

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer.

Lili Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.